What's new

Human medicines European public assessment report (EPAR): Jaypirca, pirtobrutinib, Date of authorisation: 30/10/2023, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Jaypirca, pirtobrutinib, Date of authorisation: 30/10/2023, Revision: 2, Status: Authorised

Apr 25, 2025 - 12:55
 0
Human medicines European public assessment report (EPAR): Jaypirca, pirtobrutinib, Date of authorisation: 30/10/2023, Revision: 2, Status: Authorised
Human medicines European public assessment report (EPAR): Jaypirca, pirtobrutinib, Date of authorisation: 30/10/2023, Revision: 2, Status: Authorised
Read More

Tags:

Previous Article

Yeomans adds tree-planting scheme to drive sustainability in aftersales

Next Article

We Paid Off $500K in Debt: Now We’re on Track to Retire (Early) in Our 50s

Related Posts

Human medicines European public assessment report (EPAR): Seladelpar Gilead, Seladelpar lysine dihydrate, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 24, 2025  0

Human medicines European public assessment report (EPAR): Inovelon, rufinamide, Date of authorisation: 16/01/2007, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 15, 2025  0

Human medicines European public assessment report (EPAR): Yuflyma, adalimumab, Date of authorisation: 11/02/2021, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 27, 2025  0